Superworth

TELA Bio profit margin TELA

Gross, operating and net profit as a share of revenue over the last twelve months, from 2023.

Net margin, 12 months
−51.5%
Operating margin, 12 months
−42.6%
Net margin on a year earlier
+2.6 pts
Peer median
8.4%

Over the twelve months to Jun 30, 2026, TELA Bio kept −51.5% of its revenue as net profit, with an operating margin of −42.6% and a gross margin of 67.8%.

The median for 7 medical instruments and supplies stocks of a similar size is 8.4%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−48.4%−42.0%67.7%
FY2024−54.6%−49.2%67.1%
FY2023−79.8%−75.4%68.6%
FY2022n/a−94.2%65.3%
FY2021n/a−100.0%63.9%
FY2020n/an/a61.7%
FY2019n/an/a60.0%
FY2018n/an/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−51.5%+2.6 pts−42.6%
Q1 FY26−49.3%+11.7 pts−41.8%
Q4 FY25−48.4%+6.2 pts−42.0%
Q3 FY25−50.6%+9.9 pts−46.0%
Q2 FY25−54.1%+10.9 pts−49.5%
Q1 FY25−61.0%+2.8 pts−55.8%
Q4 FY24−54.6%+25.2 pts−49.2%
Q3 FY24−60.5%+21.9 pts−55.4%
Q2 FY24−65.0%+23.4 pts−60.0%
Q1 FY24−63.8%n/a−59.6%
Q4 FY23−79.8%n/a−75.4%
Q3 FY23−82.4%n/a−77.7%

Against its peers

Companies in Medical - Instruments & Supplies nearest TELA Bio's size, closest first, today.

CompanyProfit margin
TELATELA Bio−51.5%
NEPHNephros8.4%
APTAlpha Pro Tech6.8%
KEQUKewaunee Scientific3.0%
PDEXPro DEX17.6%
UTMDUtah Medical Products29.0%
INFUInfuSystem6.0%
EMBCEmbecta8.6%
Peer median8.4%

Where TELA Bio ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on TELA Bio

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.